Position in LH
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,680
+$80 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,012
of 1,046 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ALBION FINANCIAL GROUP /UT holds $13,727,883 across 8 Diagnostics & Research names. LH ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,162 | $12,113,860 | |
| 2 | A |
Agilent Technologies, Inc.
|
10,160 | $1,349,552 | |
| 3 | DHR |
Danaher Corp /De/
|
1,290 | $245,719 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
21 | $11,055 | |
| 5 | WAT |
Waters Corp /De/
|
15 | $5,625 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
6 | $1,680 | |
| 7 | ILMN |
Illumina, Inc.
|
2 | $351 | |
| 8 | IMDX |
Insight Molecular Diagnostics Inc.
|
7 | $41 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,680 | 6 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,600 | 6 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,505 | 6 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,722 | 6 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,575 | 6 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,396 | 6 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,375 | 6 | Shares | Sole | 2025-01-17 | |
| No filing history on record for this holder in this stock. | ||||||